A detailed history of Newbridge Financial Services Group, Inc. transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 1,900 shares of GLSI stock, worth $25,536. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,900
Previous 1,500 26.67%
Holding current value
$25,536
Previous $29,000 10.34%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Sep 11, 2024

BUY
$12.07 - $19.04 $4,828 - $7,616
400 Added 26.67%
1,900 $32,000
Q2 2023

Jul 21, 2023

BUY
$9.58 - $13.2 $5,748 - $7,920
600 Added 66.67%
1,500 $14,000
Q1 2023

Apr 18, 2023

BUY
$12.12 - $20.8 $4,848 - $8,320
400 Added 80.0%
900 $12,000
Q3 2021

Oct 27, 2021

BUY
$38.65 - $46.11 $19,325 - $23,055
500 New
500 $20,000

Others Institutions Holding GLSI

About Greenwich LifeSciences, Inc.


  • Ticker GLSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,848,200
  • Market Cap $173M
  • Description
  • Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...
More about GLSI
Track This Portfolio

Track Newbridge Financial Services Group, Inc. Portfolio

Follow Newbridge Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.